Formulary acceptance and Pricing

The success of your product launch can be jeopardized if the launch price is not perceived to represent the true value of the new (or renewed) product. Unless the newcomer constitutes a treatment paradigm shift, it must be built on the current treatment perception and practices as well as respond to the challenge of the available competitive alternatives.

Pricing research in the context of healthcare presents marketing executives and researchers with a lot of complications. There are many different market participants whose opinions need to be taken into consideration (prescribers, payers and end users). In addition, there is the issue of reimbursement that needs to be properly accounted for.

Throughout your product life cycle, SKIM uses market simulations to support you with the right pricing strategies. At the early stages of your product life cycle, SKIM helps you determine clinical endpoints that will later leverage your products amongst the payers based on payers' perceived unmet medical needs. Later in the product's lifecycle, SKIM's payers' research can help design a market strategy and guide the development of a rationale to leverage a drug's benefits and support its pricing while increasing a product's chances of being endorsed and listed or recommended by the payers and relevant authorities.

Please refer to Conjoint Analysis for information on the research techniques underlying pricing research in our Methodological Partner section